Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

If you notice more than one of these symptoms, it's worth discussing them with your doctor. Trouble Moving or Walking ...

Simple external cues, such as lines on the floor, can help Parkinson’s patients focus their efforts and overcome the ...

The neurodegenerative disease impacts almost 10 million people globally, who at best can hope for therapies that slow and ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about what causes Parkinson’s disease and what can be done to reduce the ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...